HomeMedical SpecialtiesDiagnosticMelanoma Canada is proud to announce, the Mole Mobile.

Melanoma Canada is proud to announce, the Mole Mobile.

Published on

Melanoma Canada is proud to announce, the Mole Mobile, mobile skin cancer screening unit on wheels.

WHAT: The Mole Mobile, presented by Neutrogena®, a Kenvue brand, is a ground-breaking initiative that underscores the importance of skin cancer. The Mole Mobile will visit major Canadian cities with long wait times to see a dermatologist, underserved communities, rural and Indigenous regions to help speed up the time to diagnosis, which is vital to improving outcomes for patients. 

Why does Canada need the Mole Mobile? 

Melanoma and skin cancer are one of the few cancers with incidence rates on the rise in Canada and worldwide. Incidence rates for new melanoma cases have been rising on average by 1.4% each year over the last ten years. (CDC Statistics, 2016) 1 in 3 cancers diagnosed is skin cancer. Skin cancers are the most common type of cancer diagnosed in men over 49 years of age and are among the most common cancers diagnosed in youth and young adults. If detected, early melanoma and skin cancers are largely treatable. 

This year’s tour will operate with the support and partnership of the Canadian Dermatology Association (CDA). It will bring certified Canadian dermatologists to communities across British Columbia, Alberta, Quebec, and Ontario to conduct potentially lifesaving skin cancer screenings and provide education on skin cancer prevention and the importance of early detection to improve outcomes. 

Skin cancer is the most common cancer in Canada, yet access to dermatologists remains a challenge. With two Mole Mobile units hitting the road in 2025, we are expanding our reach and breaking down even more barriers to early detection. 

During Melanoma Canada’s recent Mole Mobile launch in Ontario, in just twenty stops, 1575 individuals were screened for skin cancer. Among them, Dermatologists identified 165 possible skin cancers, including 67 melanomas (a potentially deadly type of skin cancer). Each of these individuals were advised on appropriate next steps to ensure timely follow-up care. 

For more information and the Mole Mobile’s schedule, visit molemobile.ca. 

Latest articles

Nearly 300,000 Ontarians left emergency room without treatment last year

Across Canada, over 1.2 million patients left emergency rooms untreated last year. The number of...

Expanding access to prenatal education with new online modules for high-risk pregnant patients

Expecting a baby can be both exciting and overwhelming, particularly for families navigating a...

UHN’s first Emergency Preparedness Specialist reimagined how to prepare for and respond to emergencies

HN Summary • Trailblazing role: Natasha Bloomberg, UHN’s first Emergency Preparedness Specialist, is retiring after...

Putting patients first and enhancing ED communication

To improve communications and ensure patients feel supported from the moment they enter the...

More like this

Concordia researchers create faster way to trace how diseases spread indoors

HN Summary • New tracking method developed: Concordia researchers created a faster way to monitor...

Type 1 diabetes in children can be linked to other types of diabetes in parents

HN Summary • Parental diabetes linked to childhood type 1 diabetes:  New research shows that...

Predicting Kidney Risk and Survival in Diabetes Mellitus

Scientists reveal how simple blood markers predict risks of kidney disease and death in...

Investigating leukemia cell lineages

B lymphocytes (B-cells) are a type of white blood cell important for immune function....

Childhood cancer care is closer to home thanks to POGO’s Satellite Clinic Network

A childhood cancer diagnosis changes every aspect of life as families know it. For...

TELUS Health for Good™ and Victoria Cool Aid Society launch series of hepatitis C testing events in Victoria

Today, Victoria Cool Aid Society and TELUS Health for Good launched a series of hepatitis C testing...